paper_id,claim,figure_id,title,caption,local_image_path,url
PMC5596700,Simulation results regarding the baseline cumulative incidence functions are presented in Figure 1.,PMC5596700_figure_1,Figure 1.,"True (grey lines) and average estimated (black dashed lines) baseline cumulative incidence functions based on 1,000 simulation replications according to cause of failure and sample size n.",./data/PMC5596700/images/figure_1.jpg,https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae2c/5596700/f5b166dd571a/nihms874574f1.jpg
PMC5596700,A schema of typical patient temporal trajectories is presented in Figure 2.,PMC5596700_figure_2,Figure 2.,Example of four patients in a typical HIV care and treatment program.,./data/PMC5596700/images/figure_2.jpg,https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae2c/5596700/b25b6481952b/nihms874574f2.jpg
PMC5596700,"Figure 3 presents results of these quantities, based on the estimates from the optimal model, for a female patient with CD4 count at ART initiation of 120 cells/μl, by age at ART initiation.",PMC5596700_figure_3,Figure 3.,"Estimated cumulative incidence of loss to care (top left panel) and of death (top right panel) for a female patient with a CD4 count of 120 cells/μl at ART initiation, according to age at ART initiation (solid lines = 20 years; dashed lines = 30 years; dotted lines = 40 years; dashed-dotted lines = 50 years) based on the optimal model according to the grid search, with α = (2, 1.2), and estimated cumulative incidence of loss to care (bottom left panel) and of death (bottom right panel) for a male patient with a CD4 count of 120 cells/μl at ART initiation, according to age (solid lines = 20 years; dashed-dotted lines = 50 years), based on the optimal model (black lines) and the Fine-Gray – proportional odds model (gray lines) with α = (0, 1).",./data/PMC5596700/images/figure_3.jpg,https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae2c/5596700/9e51981faa7f/nihms874574f3.jpg
PMC5596700,The comparison between the predictions from the optimal model and the FGPO model are presented in the bottom row of Figure 3.,PMC5596700_figure_3,Figure 3.,"Estimated cumulative incidence of loss to care (top left panel) and of death (top right panel) for a female patient with a CD4 count of 120 cells/μl at ART initiation, according to age at ART initiation (solid lines = 20 years; dashed lines = 30 years; dotted lines = 40 years; dashed-dotted lines = 50 years) based on the optimal model according to the grid search, with α = (2, 1.2), and estimated cumulative incidence of loss to care (bottom left panel) and of death (bottom right panel) for a male patient with a CD4 count of 120 cells/μl at ART initiation, according to age (solid lines = 20 years; dashed-dotted lines = 50 years), based on the optimal model (black lines) and the Fine-Gray – proportional odds model (gray lines) with α = (0, 1).",./data/PMC5596700/images/figure_3.jpg,https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae2c/5596700/9e51981faa7f/nihms874574f3.jpg
PMC5596700,"Plotting the object 
f20.01 in the example above (e.g., with the 
plot function) will provide the estimated cumulative incidences that are depicted in the second row of Figure 3 as solid grey lines.Proof of consistency
Empirical process theory techniques will be applied to derive the consistency of the B-spline sieve maximum likelihood estimator.",PMC5596700_figure_3,Figure 3.,"Estimated cumulative incidence of loss to care (top left panel) and of death (top right panel) for a female patient with a CD4 count of 120 cells/μl at ART initiation, according to age at ART initiation (solid lines = 20 years; dashed lines = 30 years; dotted lines = 40 years; dashed-dotted lines = 50 years) based on the optimal model according to the grid search, with α = (2, 1.2), and estimated cumulative incidence of loss to care (bottom left panel) and of death (bottom right panel) for a male patient with a CD4 count of 120 cells/μl at ART initiation, according to age (solid lines = 20 years; dashed-dotted lines = 50 years), based on the optimal model (black lines) and the Fine-Gray – proportional odds model (gray lines) with α = (0, 1).",./data/PMC5596700/images/figure_3.jpg,https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae2c/5596700/9e51981faa7f/nihms874574f3.jpg
PMC5596700,"Plotting the object 
f20.01 in the example above (e.g., with the 
plot function) will provide the estimated cumulative incidences that are depicted in the second row of Figure 3 as solid grey lines.",PMC5596700_figure_3,Figure 3.,"Estimated cumulative incidence of loss to care (top left panel) and of death (top right panel) for a female patient with a CD4 count of 120 cells/μl at ART initiation, according to age at ART initiation (solid lines = 20 years; dashed lines = 30 years; dotted lines = 40 years; dashed-dotted lines = 50 years) based on the optimal model according to the grid search, with α = (2, 1.2), and estimated cumulative incidence of loss to care (bottom left panel) and of death (bottom right panel) for a male patient with a CD4 count of 120 cells/μl at ART initiation, according to age (solid lines = 20 years; dashed-dotted lines = 50 years), based on the optimal model (black lines) and the Fine-Gray – proportional odds model (gray lines) with α = (0, 1).",./data/PMC5596700/images/figure_3.jpg,https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae2c/5596700/9e51981faa7f/nihms874574f3.jpg
